Focus on concluding strategic and/or partnership agreements, in particular a licence agreement in the United States for the NCX 470
Effective on July 28, 2022.
Doug Hubatsch will lead clinical and non-clinical development.
Its territories in Colombia, Hong Kong, Taiwan and Ukraine receives approval from the U.S. Food and Drug Administration.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Tons of business ideas for eyecare professionals!
Advertisement